Verastem | VSTM - Market Capitalization

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $147.7M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Alaunos Therapeutics USD 5M 2M Sep/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
Curis USD 75M 36M Dec/2023
Cytokinetics USD 6.58B 2.63B Sep/2025
Gilead Sciences USD 183.59B 31.31B Feb/2026
Incyte USD 22.46B 3.07B Feb/2026
Laboratory Of America USD 23.83B 1.85B Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 5.74B 21M Sep/2025
Verastem USD 205M 17M Sep/2023